PCV13: Effective Against First-Episode CAP in Older Adults

Slideshow

The 13-valent pneumococcal conjugate vaccine reduced nearly by half vaccine-type community acquired pneumonia in adults aged 65 years and older.

Recent Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
Related Content
Sanofi Investigational COVID-19/Influenza Combination Vaccines Granted FDA Fast-Track Designation / image credit ©Katyeryna_Kon/shutterstock.com

Sanofi Investigational COVID-19/Influenza Combination Vaccines Granted FDA Fast-Track Designation

Grace Halsey
December 18th 2024
Article

The 2 novel vaccine candidates each combine a Sanofi licensed influenza vaccine with the Novavax adjuvanted recombinant COVID-19 vaccine.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

Flu, COVID-19, RSV Vaccine Uptake Low Among US Adults in 2024-2025 Season / Image credit: ©Tan/AdobeStock

Flu, COVID-19, RSV Vaccine Uptake Low Among US Adults in 2024-2025 Season

Sydney Jennings
December 4th 2024
Article

Many unvaccinated adults reported intent to get vaccinated, according to early season estimates released in MMWR.

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

Sydney Jennings
May 20th 2022
Podcast

In our latest podcast episode, Njira Lugogo, MD, discusses NAVIGATOR data she presented at ATS 2022 that showed clinical responses to treatment with tezepelumab.

Respiratory Virus Season 2024-2025: Expert Insights to Help Primary Care Prepare

Respiratory Virus Season 2024-2025: Expert Insights to Help Primary Care Prepare

Sydney Jennings
November 11th 2024
Article

Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.

Social, Racial Disparities in Flu, COVID-19, RSV Vaccine Uptake: Daily Dose / image credit: ©New Africa/AdobeStock

Social, Racial Disparities in Flu, COVID-19, RSV Vaccine Uptake: Daily Dose

Sydney Jennings
October 31st 2024
Article

Your daily dose of the clinical news you may have missed.

© 2024 MJH Life Sciences

All rights reserved.